Additionally, patients with spondyloarthropathy or adult RA who responded favorably to the anti-TNF-α monoclonal antibody infliximab showed a rapid and marked decrease in the level of MRP-positive macrophages in tissue infiltrates, but not in the total population of resident macrophages [43]. The gene discussed is TNF; the disease is spondyloarthropathy.